Clinical Study
Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
Figure 4
Relationship between expression of CD155, cell counts of TILs, and PD-1 expression. (a) Cell count of TILs. (b) PD-1 status among patients with low expression of CD155. (c) PD-1 status among patients with overexpression of CD155. (d) Percentage of PD-1+ TILs. (e) Cell count of PD-1+ TILs.
(a) |
(b) |
(c) |
(d) |
(e) |